Donnini, F.; Minniti, G.; Chibbaro, S.; Bagnacci, G.; Perrella, A.; Battaglia, G.; Rubino, G.; Pastina, P.; Carfagno, T.; Vannini, M.;
et al. Reduced Clinical Target Volume Margins in Glioblastoma: Exploratory Evidence Supporting Further Margin Reduction Independent of MGMT Status. Brain Sci. 2026, 16, 458.
https://doi.org/10.3390/brainsci16050458
AMA Style
Donnini F, Minniti G, Chibbaro S, Bagnacci G, Perrella A, Battaglia G, Rubino G, Pastina P, Carfagno T, Vannini M,
et al. Reduced Clinical Target Volume Margins in Glioblastoma: Exploratory Evidence Supporting Further Margin Reduction Independent of MGMT Status. Brain Sciences. 2026; 16(5):458.
https://doi.org/10.3390/brainsci16050458
Chicago/Turabian Style
Donnini, Flavio, Giuseppe Minniti, Salvatore Chibbaro, Giulio Bagnacci, Armando Perrella, Giuseppe Battaglia, Giovanni Rubino, Pierpaolo Pastina, Tommaso Carfagno, Marta Vannini,
and et al. 2026. "Reduced Clinical Target Volume Margins in Glioblastoma: Exploratory Evidence Supporting Further Margin Reduction Independent of MGMT Status" Brain Sciences 16, no. 5: 458.
https://doi.org/10.3390/brainsci16050458
APA Style
Donnini, F., Minniti, G., Chibbaro, S., Bagnacci, G., Perrella, A., Battaglia, G., Rubino, G., Pastina, P., Carfagno, T., Vannini, M., Mazzei, M. A., Cerase, A., & Tini, P.
(2026). Reduced Clinical Target Volume Margins in Glioblastoma: Exploratory Evidence Supporting Further Margin Reduction Independent of MGMT Status. Brain Sciences, 16(5), 458.
https://doi.org/10.3390/brainsci16050458
